September 2020 - Prof. Francisco Javier Quintana of Brigham and Women’s Hospital Harvard Medical School, a world-renowned expert in immune regulation and tolerance, joins Alma’s scientific advisory board.
July 2020 - Alma Bio Therapeutics was among the recipients of PGE, the French government state guaranteed loan.
March 2020 - Alma Bio Therapeutics participated at Digital BioEurope Spring
March 2020 - Alma Bio Theraeutics presented at the RESI Digital partnering event
December 2019 - Alma Bio Therapeutics will be attending the French-Israeli joint event in the healthcare sector, Paris December 10, 2019, sponsored by the BPI, the French Public Investment Bank. As part…
December 2019 - Alma has been invited to present at the EIT Health Summit 2019, December 2-3 Paris. Come and meet us there.
October 2019 - Alma receives the EMA's CHMP (Committee for Medicinal Products for Human Use) scientific advice. The Agency's advice concerned quality development, pre-clinical development and clinical development for the…
August 2019 - Alma is featured in Cello Health BioConsulting's "Next-generation-therapies-for-autoimmune-and-inflammatory-diseases". Alma is listed among the "next generation approaches in development with novel targets and modalities"
January 2019 - Alma appointed Dr. Alain P. Rolland to serve on its scientific advisory board. Dr. Rolland's appointment will strengthen Alma's capacities in the fields of DNA drugs and…
Dr Binah Baum, Alma Bio Therapeutics CEO, was at the Health Investor Day in Paris on June 24th-25th, 2019.